Rankings
▼
Calendar
AUPH Q1 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30,000
+0.0% YoY
Gross Profit
-$11M
-35336.7% margin
Operating Income
-$15M
-49616.7% margin
Net Income
-$12M
-41426.7% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+3.4%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$165M
Total Liabilities
$25M
Stockholders' Equity
$139M
Cash & Equivalents
$140M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30,000
$30,000
+0.0%
Gross Profit
-$11M
-$9M
-19.7%
Operating Income
-$15M
-$13M
-14.1%
Net Income
-$12M
-$15M
+19.7%
← FY 2019
All Quarters
Q2 2019 →